Menu Search
Equities

Serstech AB

284:FRA

Serstech AB

Actions
  • Price (EUR)0.0789
  • Today's Change0.007 / 10.50%
  • Shares traded1.00k
  • 1 Year change+110.96%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Serstech AB is a Sweden-based developer of micro-spectrometers. The Company's products split light into various wavelengths to identify drugs, and explosive and hazardous materials. The Company offers micro-spectrometer chips, which are optical components integrated on chips for the measurement of color, absorption, fluorescence, and Raman spectra; micro-spectrometer-boards; surface enhanced Raman spectroscopy surfaces that provide various orders of magnitude amplification in independent tests; and custom spectrometers. The Company offers its products for security, defense, industry, med-tech, and clean-tech application areas. It serves customers such as police, rescue, customs, and defense officers to identify powders, pills, and fluids.

  • Revenue in SEK (TTM)53.35m
  • Net income in SEK-7.54m
  • Incorporated2006
  • Employees24.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.